Hematologic Toxicity on RTOG 0418: A Phase II Study of Post-operative IMRT for Gynecologic Cancer

Reviewer: Lara Bonner Millar, MD
The Abramson Cancer Center of the University of Pennsylvania
Ultima Vez Modificado: 3 de noviembre del 2010

Translation for this article does not exist

Blogs

Cancer and Hair Loss
by Bob Riter
February 11, 2016

From the National Cancer Institute